tbuckley/cabot-search huggingface dataset:
Defibrillation-Reply
Authors: Richard S. Crampton
Journal: JAMA (1976)

Although variables other than body weight influence ventricular defibrillation, paddle size and electrical waveform and its duration have not impeded successful low energy defibrillation by the four devices used by Pantridge's group and ours. Yakaitis and Redding suggest Pantridge's successful low-energy defibrillation may be due to "2 minutes or less" of ventricular fibrillation as compared to Tacker's "5 minutes or less." Although duration of fibrillation was known, we previously have pointed out the most logical explanation for the low- versus high-energy discrepancy is that Pantridge's group and ours have investigated human defibrillation prospectively instead of retrospectively as Tacker et al have. Pantridge et al have studied a total of 120 patients, up to 145 kg in weight, with 222 successful defibrillations.<sup>1</sup>Our experience has increased to 14 patients averaging 75.2 kg (range, 48.5 to 101.0 kg) with 35 successful defibrillations after delivering an average of 170 joules
Reply
Authors: L. Dernevik
Journal: Thorax (1986)

Exogenous particles in lymph nodes in patients with shrinking pleuritis with atelectasis SIR,-I am rather surprised that Dr Dernevik (December 1985;40:948-51) uses the term shrinking pleuritis with atelectasis in preference to the more descriptive term of round atelectasis.This interesting form of lung collapse has been well described by Hanke and Kretzschmar, who advo- cate the term round atelectasis.In 1980 they reported experi- ence with 80 cases of this condition and pointed out its specific radiological features.'This benign condition is often mistaken for a bronchial carcinoma.In view of this, its recognition is of prime importance to avoid unnecessary invasive tests and tho- racotomies.Since I became aware of the condition I have accumulated 10 cases over the last three years.Thoracotomy was avoided in eight patients.The remaining two each had bronchial carcinoma with pleural effusion, which resulted in the formation of the round atelectasis.In this very small series only one case was related to asbestos exposure.All except two of the others had pleural effusions.It is advisable to consider the possibility of round atelectasis when assessing subpleural opacities, especially those seen in the lower zones of the lung fields.Awareness of this condition will prove to be beneficial.
Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum- hepatitis B surface antigen
Authors: H Hsu
Journal: Hepatology (1996)

The immune responses to hepatitis B vaccine were studied in 11 hepatitis B surface antigen (HBsAg) carrier children who had cleared HBsAg but failed to develop hepatitis B surface antigen antibodies (anti-HBs) in sera (group 1), 5 HBsAg carrier children who had cleared HBsAg and developed detectable anti-HBs in sera (group 2), and 5 healthy subjects seronegative for all hepatitis B virus (HBV) markers (group 3). After receiving three doses of HB vaccine, group 1 subjects failed to develop detectable anti-HBs. Subsequently, each subject of the three groups was given one dose of the same vaccine for a cellular immunity study, and a measurable proliferation of peripheral blood mononuclear cells (PBMC) to HBsAg was detected in 1 of 8 (12.5%), 0 of 5, and 4 of 5 (80%) of the cases in each group, respectively, after vaccination. The removal of CD8+ cells enhanced the HBsAg blastogenic response in group 3 but did not reverse the unresponsiveness in group 1 and group 2 subjects. The addition of interleukin (IL)-2 in culture reversed unresponsiveness in all cases except one case in group 1. Compared with before vaccination, PBMC from group 2 subjects produced significantly less interferon gamma (IFN-gamma) and more IL-4 in response to HBsAg after vaccination, a cytokine response not observed in group 1 subjects. HLA typing indicated that 3 of 10 patients in group 1 (30%) and 1 of 5 patients in group 2 (20%) had HLA-DRw14-DRw52, a marker previously linked to low anti-HBs response to hepatitis B vaccine in Taiwan. We conclude that the underlying causes of poor anti-HBs response in group 1 subjects are multifactorial, including specific failure of antigen presentation or T-cell activation, or the lack of T helper (Th)2 cell-like response to HBsAg. HLA-DRw14-DRw52 does not confer absolute nonresponsiveness to HBsAg. These patients are not benefited by hepatitis B immunization.
Early signs of congenital dislocation of the hip
Authors: A. L. Matles
Journal: JAMA (1966)

<h3>To the Editor:—</h3> I am sure your readers, and your editorial board, will join with me in welcoming a new medical journal to the lists of those already in press. The importance of this occasion may not be apparent to all, wherefore this letter. Earlier in my speckled career I argued that all men and women should have a medical education. Instead of high schools and colleges devoted to teaching the liberal arts, we should have medical schools. These would teach only the amount of algebra and syntax essential to understanding the stethoscope or to grasp the import of the<i>culmen</i>of the<i>monticulus.</i>Such esoteric and recondite subjects as economics or poetry would be strictly postgraduate pursuits, outlawed for study until after the MD had been bestowed: "The dithyramb 'twere a naughty thing, Ere dunked in th'Aesculapian spring." The advantages of such a system of education, although clear to
A National Health Program-Reply
Journal: JAMA (1990)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Antiphospholipid Antibodies
Authors: Caron P. Misita, Stephan Moll
Journal: Circulation (2005)

ntiphospholipid antibodies (APLAs) are proteins that may be present in the blood and may increase your risk for blood clots or pregnancy losses.If you have a history of blood clots or recurrent pregnancy losses, you may have been tested for the presence of APLAs in your blood.The purpose of this Cardiology Patient Page is to provide information for persons with APLAs about the disorder and appropriate treatment.
Reply to: “Response: Distinguishing Stevens-Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation—A retrospective chart review”
Authors: Allison Weinkle, Benjamin H. Kaffenberger, John C. Trinidad, Elizabeth N. Ergen, Jesse Keller, Lucia Seminario-Vidal
Journal: Journal of the American Academy of Dermatology (2019)
Deprescription Mosaic—The Art of Geriatrics
Journal: JAMA Internal Medicine (2019)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Internal Medicine HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Internal Medicine journal
Multiple viral infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: Application and limitations of the polymerase chain reaction
Authors: J Wu
Journal: Hepatology (1994)

We tested serum samples from 25 fulminant hepatitis and 7 subfulminant hepatitis patients for hepatitis A, B, C, D and E viral markers and nucleic acids by means of polymerase chain reaction to determine the role of each virus on such catastrophic events in an area endemic for hepatitis B. Of these 32 patients, 14 (44%) were hepatitis B virus carriers with hepatitis D virus superinfection (1 with hepatitis C virus infection), 3 others had coexisting hepatitis B virus and hepatitis C virus infections, 6 had reactivation of underlying chronic hepatitis B, 4 had acute hepatitis B, 2 had acute hepatitis C and 1 had acute hepatitis E. Pathogenesis in the remaining two cases was unclear. Serum hepatitis B virus DNA was detectable in most carriers without superinfection and in one third of those with superinfection detected on polymerase chain reaction (6 of 7 vs. 6 of 16, p < 0.05). Of the polymerase chain reaction–positive samples, only 17% yielded positive results on spot hybridization. Hepatitis B virus DNA was the only marker to indicate coexisting hepatitis B virus infection in one patient positive for hepatitis C virus antibody. Only three of the six hepatitis C virus–infected cases were positive for hepatitis C virus antibody; diagnoses in the remaining three were established by means of detection of hepatitis C virus RNA. Of the hepatitis D virus–infected patients, infection in only half was diagnosed by means of total hepatitis D virus antibody assay. Twelve (86%) were positive for anti-hepatitis D virus IgM and nine (64%) had detectable hepatitis D virus RNA on reverse transcription–polymerase chain reaction. Only one third of reverse transcription–polymerase chain reaction positive cases had positive results on Northern-blot hybridization. Hepatitis D virus RNA was the only marker indicating hepatitis D virus infection in two (14%) of the hepatitis D virus–infected patients. In conclusion, most fulminant and subfulminant viral hepatitis in Taiwan is caused by multiple viral infection (hepatitis B virus with hepatitis D virus or hepatitis C virus), which might be underestimated if only one kind of marker were used. (HEPATOLOGY 1994;19:836–840.)
Media Dissemination of and Public Response to the Ultraviolet Index—United States, 1994-1995
Journal: JAMA (1997)

Exposure to the ultraviolet component of sunlight may be associated with an increased risk for some skin cancers. The Ultraviolet Index (UVI) links a rating by the National Weather Service (NWS) of solar ultraviolet intensity (on a scale of 0 [minimal] to 10+ [very high]) to recommendations for appropriate sun-protection behaviors. During the summers of 1994 and 1995, the NWS, in collaboration with the Environmental Protection Agency (EPA), the American Academy of Dermatology, the National Association of Physicians for the Environment, and CDC, disseminated UVI forecasts to selected major television stations and newspapers in the United States. In 1995, the Boston University School of Medicine conducted three surveys to evaluate how widely the UVI was televised, printed in newspapers, and used by adults (aged > or = 18 years) to modify their behaviors to reduce exposure to ultraviolet light. This report summarizes the findings of the elevation, which indicate generally high rates of television broadcast and public awareness of the UVI.
DIGITAL EXTUBATION
Authors: John Leshure
Journal: JAMA (1924)

<h3>To the Editor:</h3> —Both methods mentioned differ in several respects from the one I described, chiefly in that the patient is removed from bed and is subjected to considerable manipulation. In Renault's method, the child sits in an upright position while Marfan lays it on a table on its abdomen, with the head hanging over the edge of the table. No doubt, any of these methods will give excellent results; but all will agree that the recumbent position is best for a patient who has passed through the toxemia of diphtheria. Digital extubation has been practiced more or less since the days of O'Dwyer, and I make no claim for any originality of the method in question. Dr. H. B. Sheffield of New York has brought to my notice his description of digital extubation (<i>M. Rec.</i><b>92</b>:1068 [Dec. 22] 1917): "Occasionally one succeeds in removing the tube by 'stripping'
HEALTH OF EUROPEANS IN EAST AFRICA.
Journal: JAMA (1890)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
MEDICAL FEES
Journal: JAMA (1990)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Exposure in utero to diethylstilbestrol and related synthetic hormones. Association with vaginal and cervical cancers and other abnormalities
Journal: JAMA (1976)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Cost Savings and Prescribing Protocols for Nonsteroidal Anti-inflammatory Drugs
Authors: Bruce M. Rothschild
Journal: JAMA (1996)

<h3>To the Editor.</h3> —The article by Dr Jones and colleagues<sup>1</sup>presents an important but limited perspective of nonsteroidal anti-inflammatory drug (NSAID) prescription. While NSAID expenses are substantial, the major expenses are actually indirect—treatment of adverse effects and inadequate treatment of underlying diseases. Clinicians may wonder if cost savings still exist once the costs of treating ulcers, gastrointestinal bleeding, and other complications are considered. Given that 30% of indomethacin recipients have adverse effects of sufficient severity to require discontinuation,<sup>2</sup>it is surprising that indomethacin would be considered a first-line medication. Physician perception of patient harm may not accurately reflect patient experience. Chart review (to document adverse effects, hospitalizations, or both) would be of interest. Patients who develop hospitalization-requiring adverse effects of medication often find themselves under the care of another physician (for that hospitalization) and may elect to obtain subsequent care elsewhere. Thus, physician perception may underestimate the frequency
Can Europe lead the transformation of the plastic pollution crisis?
Authors: None The Lancet Planetary Health
Journal: The Lancet Planetary Health (2018)

Plastic production around the world has grown faster than that of any other material since the 1950s. More waste has been generated in the first decade of this millennium than in previous years. This has largely been due to the increasing manufacture of plastic products that are meant to be discarded after one use, so-called single-use plastics. Single-use plastics can be very useful, for example as low-cost hygienic medical plastics. However, its durability also presents significant challenges for the planet we are living in, posing many threats to human health.
Beyond Proof
Authors: Sanjay Sethi
Journal: Annals of Internal Medicine (1994)

Ad Libitum15 November 1994Beyond ProofSanjay SethiSanjay SethiSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-121-10-199411150-00015 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail A need to believein beyond what I perceive.A need to existbeyond this conundrum of lifeand death.But,logic and reasonnurtured by years ofrandomized controlled trialsand statistical probabilitiesdemandproof.Using one's mindto save lives.And thento tell the mind that youare hindering my salvation;that all you see and know isa mirage;that what is true isbeyond you.Daily encounterswith sickness and death.Wonderful people suffering.Hard to fathom thatdivine graceis guiding, underlyingit all.To be condemned to bethe highest animaltemporarily at the pinnacleof evolution.Life,are you really so mundane? Author, Article, and Disclosure InformationAffiliations: Previousarticle Advertisement FiguresReferencesRelatedDetails Metrics 15 November 1994Volume 121, Issue 10Page: 814 ePublished: 15 August 2000 Issue Published: 15 November 1994 Copyright & PermissionsCopyright © 1994 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Contusion Angle Deformity and Glaucoma
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations
Authors: Jens Mogensen, Toru Kubo, Mauricio Duque, William Uribe, Anthony Shaw, Ross Murphy, Juan R. Gimeno, Perry Elliott, William J. McKenna
Journal: Journal of Clinical Investigation (2003)

Mutation analysis of TNNI3 by direct sequencing identified a 87A→G nucleotide substitution of exon 8 resulting in an Asp190Gly amino acid substitution that segregated with the disease in the family (maximal two-point lode score: 4.8).Direct sequencing of TNNI3 identified a 93G→A nucleotide substitution of exon 8, which resulted in an Arg192His amino acid substitution.
List of Contributors
Authors: Chase Patterson Kimball, Margaret Thaler Singer, Harley C. Shands, P.-B. Schneider, Peter E. Sifneos, Roberta Apfel-Savitz, Fred H. Frankel, Heinz H. Wolff, George Spyros Philippopoulos, Louis A. Gottschalk, M. von Rad, L. Lalucat, F. Lolas, R. Vogt, G. Bürckstümmer, L. Ernst, K. Meyer, M. von Rad, W. Bräutigam, M. von Rad, G. Overbeck, Graeme J. Taylor, John C. Nemiah, Paul D. MacLean, Astrid Heiberg, Arvid Heiberg, Johannes Cremerius, Helm Stierlin, M. Wirsching, W. Knauss, E.M. Waring, Renata Gaddini, M. Mitscherlich, S. Zepf, Jan Bastiaans, H. Becker, Hellmuth Freyberger, S. Stephanos, U. Auhagen, A. Sellschopp-Rüppell, M. von Rad, Karola Brede, Frode Larsen, Truls-Eirik Mogstad, B. Waysfeld, M. Le Barzic, P. Aimez, B. Guy-Grand, John G. Flannery, Klaus D. Hoppe, Joseph E. Bogen, R. Pierloot, J. Vinck, John C. Nemiah, Peter E. Sifneos, Roberta Apfel-Savitz, Fred H. Frankel, Roberta Apfel-Savitz, John C. Nemiah, Peter E. Sifneos, Murray Jackson, R. Liedtke, H. Freyberger, S. Zepf, R. Borens, E. Grosse-Schulte, W. Jaensch, K.-H. Kortemme, Charles V. Ford, Kahlila D. Long, J.P. Roberts, A. Sellschopp-Rüppell, Roberta Apfel-Savitz, Daniel Silverman, Michael I. Bennett, H.H. Wolff
Journal: Psychotherapy and Psychosomatics (1977)